Ameritas Investment Company’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$344K Buy
4,201
+791
+23% +$71.2K 0.02% 519
2021
Q2
$428K Sell
3,410
-755
-18% -$67.2K 0.02% 454
2021
Q1
$356K Buy
4,165
+1,462
+54% +$131K 0.03% 426
2020
Q4
$254K Buy
+2,703
New +$236K 0.05% 345
2020
Q2
Sell
-1,207
Closed -$100K 1167
2020
Q1
$100K Buy
1,207
+499
+70% +$44.5K 0.02% 500
2019
Q4
$67K Buy
708
+156
+28% +$14K 0.01% 531
2019
Q3
$48K Buy
+552
New +$49.6K 0.01% 670
2019
Q2
Sell
-239
Closed -$21K 647
2019
Q1
$21K Sell
239
-2,586
-92% -$208K ﹤0.01% 542
2018
Q4
$217K Buy
+2,825
New +$220K 0.05% 279

Other funds holding NVS

Ameritas Investment Company's NVS Position: Q3 2021 in Review

Ameritas Investment Company increased its Novartis (NVS) stake by 23% in Q3 2021, buying an estimated $71.2K and bringing the position to 4,201 shares worth $344K. The position accounts for 0.02% of the portfolio, ranked #519.

Ameritas Investment Company first reported a position in NVS in Q4 2018 and has held it in 9 quarters since. The position peaked at $428K in Q2 2021. 1,081 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

  • Ameritas Investment Company held 4,201 shares of Novartis worth $344K as of Q3 2021.
  • Ameritas Investment Company bought 791 Novartis shares in Q3 2021, an estimated $71.2K.
  • Novartis made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #519 holding.
  • Ameritas Investment Company first reported a position in Novartis in Q4 2018 and has held it in 9 quarters since.
  • Ameritas Investment Company's Novartis position peaked at $428K in Q2 2021.
  • 1,081 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.